World's Best-Selling Med; Cost-Effectiveness of GLP-1 Drugs; TED Drug Heads to FDA

(MedPage Today) — The GLP-1 receptor agonist tirzepatide (Zepbound, Mounjaro) surpassed the cancer immunotherapy drug pembrolizumab (Keytruda) as the world’s best-selling medicine. (STAT)
An Institute for Clinical and Economic Review report concluded…

Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/118306

Author :

Publish date : 2025-11-04 19:09:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

World’s Best-Selling Med; Cost-Effectiveness of GLP-1 Drugs; TED Drug Heads to FDA

RDN’s Coverage Decision; Intracoronary Stem Cell Tx; Crab-Walk Technique for M-TEER

Colon Cancer Screening Rates Way Up in Younger Adults

Related Posts

Origin story of domestic cats rewritten by genetic analysis

NHS Leaders Warn Budget Misses Key Priorities

Physicists have worked out a universal law for how objects shatter

Deadly fungus makes sick frogs jump far, possibly to find mates

MHRA Approves Inavolisib for PIK3CA-Mutated Breast Cancer

Germany: A Magnet for Foreign Doctors, but Losing Its Own

Origin story of domestic cats rewritten by genetic analysis

NHS Leaders Warn Budget Misses Key Priorities

Physicists have worked out a universal law for how objects shatter

Deadly fungus makes sick frogs jump far, possibly to find mates

MHRA Approves Inavolisib for PIK3CA-Mutated Breast Cancer

Germany: A Magnet for Foreign Doctors, but Losing Its Own

The World’s Doctors Are on the Move — Italy Is Hit Hardest

1 in 4 Swiss Patients on Dialysis Report Pruritus

Categories

Archives